Citi analyst Yigal Nochomovitz lowered ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst PT Change

Pre-Open Movers 07/29: (TYME) (MCC) (MYL) Higher; (LXRX) (ONDK) (CTB) (more...)July 29, 2019 9:28 AM Form 8-K LEXICON PHARMACEUTICALS, For: Jul 25July 29, 2019 6:03 AM UPDATE: Lexicon Pharma (LXRX) Reports Prelim. Update for Zynquista (Sotagliflozin) Type 2 Diabetes Phase 3 Program; Confirms Sanofi (SNY) to Terminate CollaborationJuly 29, 2019 5:45 AM Stifel Downgrades Lexicon Pharmaceuticals (LXRX) to HoldJuly 29, 2019 2:02 AM Lexicon Pharmaceuticals Provides Preliminary Update for Zynquista™ (Sotagliflozin) Type 2 Diabetes Phase 3 ProgramJuly 26, 2019 5:15 PM Sanofi (SNY) provided notice to Lexicon (LXRX) that it is terminating collaboration to develop, manufacture, and commercialize ZynquistaJuly 26, 2019 4:08 PM